Amgen, academic centers weigh new FDA pilot to speed early drug trials

To better combat China and Australia's dominance in expediting early-phase trials, the FDA and stakeholders are ironing out the details of a pilot program to accelerate first-in-human trials. Amgen, Memorial Sloan Kettering Cancer Center, the ...